Skip to content
10-Q/A

Quarterly Report

MANHATTAN SCIENTIFICS, INC.

0001477932-23-004114

← back to feed
Filed
May 31, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 22, 2023 559.28M sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$75K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$111K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $90K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $175K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$2.12M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$1.7M
Stockholders Equity Q1 2023 · Mar 31, 2022 $388K
Stockholders Equity Q1 2023 · Dec 31, 2021 $1.04M
Current Liabilities Q1 2023 · Mar 31, 2023 $1.75M
Current Liabilities Q1 2023 · Dec 31, 2022 $1.67M
Total Liabilities Q1 2023 · Mar 31, 2023 $1.75M
Total Liabilities Q1 2023 · Dec 31, 2022 $1.67M
Current Assets Q1 2023 · Mar 31, 2023 $115K
Current Assets Q1 2023 · Dec 31, 2022 $189K
Total Assets Q1 2023 · Mar 31, 2023 $694K
Total Assets Q1 2023 · Dec 31, 2022 $1.03M
Eps Diluted Q1 2023 · Mar 31, 2023 $0.00
Eps Diluted Q1 2023 · Mar 31, 2022 $0.00
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 $0.00
Sga Expense Q1 2023 · Mar 31, 2023 $186K
Sga Expense Q1 2023 · Mar 31, 2022 $180K
Rd Expense Q1 2023 · Mar 31, 2023 $0
Rd Expense Q1 2023 · Mar 31, 2022 $3K
Net Income Q1 2023 · Mar 31, 2023 −$420K
Net Income Q1 2023 · Mar 31, 2022 −$647K
Operating Income Q1 2023 · Mar 31, 2023 −$186K
Operating Income Q1 2023 · Mar 31, 2022 −$183K
Revenue Q1 2023 · Mar 31, 2023 $0
Revenue Q1 2023 · Mar 31, 2022 $0